• Hunter Capital RTO 1 will hold an extraordinary general meeting in Kista on November 30, 2026.
• Shareholders will vote on acquiring ResoTher Pharma through a reverse takeover.
• Proposals include issuing up to 17,228,388 shares at 15.86 Swedish kronor each in exchange for ResoTher Pharma shares.
• A proposed 1-for-12 reverse stock split would reduce existing shares from 45,405,000 to 3,783,750.
• Other proposals include renaming the company ResoTher Pharma, replacing its board and issuing replacement warrants for existing ResoTher Pharma warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunter Capital RTO 1 AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 202610300200BITN____UKPR__SV_20261029-BIT-2245-0) on October 30, 2026, and is solely responsible for the information contained therein.